Market Closed -
Nasdaq Stockholm
11:29:32 2024-05-10 EDT
|
5-day change
|
1st Jan Change
|
27
SEK
|
0.00%
|
|
-1.46%
|
+12.97%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
4,296
|
1,798
|
1,010
|
654.9
|
654.9
|
-
|
Enterprise Value (EV)
1 |
4,199
|
1,714
|
901.5
|
519.7
|
604
|
604.1
|
P/E ratio
|
-1,559
x
|
-27.6
x
|
-11.9
x
|
-6.31
x
|
-3.67
x
|
-3.6
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
28,266
x
|
4,647
x
|
1,200
x
|
432
x
|
182
x
|
63.3
x
|
EV / Revenue
|
27,624
x
|
4,429
x
|
1,071
x
|
369
x
|
168
x
|
58.4
x
|
EV / EBITDA
|
-457
x
|
-146
x
|
-53.8
x
|
-25.7
x
|
-18.8
x
|
-14
x
|
EV / FCF
|
-346,642,696
x
|
-101,345,928
x
|
-56,277,398
x
|
-
|
-
|
-
|
FCF Yield
|
-0%
|
-0%
|
-0%
|
-
|
-
|
-
|
Price to Book
|
153
x
|
2.3
x
|
1.29
x
|
0.98
x
|
1.52
x
|
1.87
x
|
Nbr of stocks (in thousands)
|
275,673
|
283,112
|
283,112
|
283,110
|
283,110
|
-
|
Reference price
2 |
15.59
|
6.352
|
3.568
|
2.313
|
2.313
|
2.313
|
Announcement Date
|
21-02-25
|
22-02-18
|
23-02-17
|
24-02-16
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
0.152
|
0.387
|
0.842
|
1.408
|
3.6
|
10.35
|
EBITDA
1 |
-9.197
|
-11.73
|
-16.76
|
-20.22
|
-32.21
|
-43.06
|
EBIT
1 |
-10.64
|
-13.14
|
-18.45
|
-21.84
|
-32.61
|
-43.45
|
Operating Margin
|
-7,000.66%
|
-3,395.61%
|
-2,190.86%
|
-1,551.14%
|
-905.7%
|
-420%
|
Earnings before Tax (EBT)
1 |
-10.32
|
-15.45
|
-21.4
|
-24.43
|
-36.5
|
-46.45
|
Net income
1 |
-10.28
|
-15.36
|
-20.82
|
-23.74
|
-36.62
|
-46.55
|
Net margin
|
-6,761.18%
|
-3,969.25%
|
-2,473.16%
|
-1,686.36%
|
-1,017.33%
|
-449.9%
|
EPS
2 |
-0.0100
|
-0.2300
|
-0.3000
|
-0.3400
|
-0.6305
|
-0.6432
|
Free Cash Flow
|
-12.11
|
-16.91
|
-16.02
|
-
|
-
|
-
|
FCF margin
|
-7,969.08%
|
-4,370.28%
|
-1,902.49%
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
21-02-25
|
22-02-18
|
23-02-17
|
24-02-16
|
-
|
-
|
Fiscal Period: December |
2021 Q2
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
0.115
|
0.083
|
0.107
|
0.198
|
0.207
|
0.195
|
0.242
|
0.307
|
0.349
|
0.244
|
0.508
|
0.54
|
0.9
|
1.26
|
0.9
|
EBITDA
1 |
-2.616
|
-3.552
|
-3.638
|
-3.986
|
-3.921
|
-4.149
|
-4.702
|
-4.469
|
-3.873
|
-5.345
|
-6.529
|
-8.394
|
-8.052
|
-7.71
|
-8.052
|
EBIT
1 |
-2.968
|
-3.904
|
-3.99
|
-4.411
|
-4.347
|
-4.581
|
-5.108
|
-4.87
|
-4.276
|
-5.752
|
-6.942
|
-8.493
|
-8.152
|
-7.809
|
-8.151
|
Operating Margin
|
-2,580.87%
|
-4,703.61%
|
-3,728.97%
|
-2,227.78%
|
-2,100%
|
-2,349.23%
|
-2,110.74%
|
-1,586.32%
|
-1,225.21%
|
-2,357.38%
|
-1,366.54%
|
-1,572.73%
|
-905.75%
|
-619.8%
|
-905.7%
|
Earnings before Tax (EBT)
1 |
-3.132
|
-4.521
|
-5.441
|
-4.902
|
-5.828
|
-5.886
|
-4.784
|
-4.769
|
-5.289
|
-5.689
|
-8.681
|
-9.389
|
-9.009
|
-8.974
|
-9.124
|
Net income
1 |
-2.875
|
-4.266
|
-6.254
|
-4.776
|
-5.762
|
-5.66
|
-4.626
|
-
|
-5.173
|
-5.442
|
-8.577
|
-9.417
|
-9.04
|
-9.011
|
-9.156
|
Net margin
|
-2,500%
|
-5,139.76%
|
-5,844.86%
|
-2,412.12%
|
-2,783.57%
|
-2,902.56%
|
-1,911.57%
|
-
|
-1,482.23%
|
-2,230.33%
|
-1,688.39%
|
-1,743.97%
|
-1,004.4%
|
-715.15%
|
-1,017.33%
|
EPS
2 |
-0.002000
|
-0.0600
|
-0.0900
|
-0.0700
|
-0.0800
|
-0.0800
|
-0.0700
|
-0.0700
|
-0.0700
|
-0.0800
|
-0.1200
|
-0.1621
|
-0.1556
|
-0.1551
|
-0.1576
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
21-08-24
|
21-11-24
|
22-02-18
|
22-05-11
|
22-08-23
|
22-11-15
|
23-02-17
|
23-05-12
|
23-08-24
|
23-11-22
|
24-02-16
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
97.5
|
84.3
|
109
|
87.9
|
50.9
|
50.8
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-12.1
|
-16.9
|
-16
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
0.1000
|
2.760
|
2.760
|
2.190
|
1.520
|
1.230
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
1.72
|
5.44
|
0.06
|
-
|
-
|
-
|
Capex / Sales
|
1,130.26%
|
1,405.94%
|
7.24%
|
-
|
-
|
-
|
Announcement Date
|
21-02-25
|
22-02-18
|
23-02-17
|
24-02-16
|
-
|
-
|
Last Close Price
2.313
EUR Average target price
3.834
EUR Spread / Average Target +65.73% Consensus |
1st Jan change
|
Capi.
|
---|
| +12.97% | 705M | | +73.46% | 12.41B | | -15.61% | 8.23B | | +3.88% | 6.46B | | +14.69% | 5.5B | | +42.58% | 5.1B | | -19.05% | 4.05B | | -32.61% | 2.54B | | -0.74% | 1.99B | | +10.80% | 1.99B |
Medical Equipment
|